ExpreS2ion Biotechnologies – Presentation of Year-End report 2021
Watch our live event where CEO of ExpreS2ion Biotechnologies, Bent Frandsen, and CFO, Keith Alexander present the Year-end report financial results. During the event, it will be possible to ask questions.
Outside the financial result, there will also be a focus on the positive pipeline topline results for its HER2-cVLP breast cancer vaccine announced both in December and January.
ExpreS2ion Biotechnologies is a Danish pharmaceutical company, which focuses on the development of vaccines. Currently the company is developing vaccines against Covid-19, breast cancer and Influenza.
Disclaimer: HC Andersen Capital receives payment from ExpreS2ion Biotechnologies for a Digital IR / Corporate Visibility subscription agreement.
ExpreS2ion Biotechnologies – Presentation of Year-End report 2021
Watch our live event where CEO of ExpreS2ion Biotechnologies, Bent Frandsen, and CFO, Keith Alexander present the Year-end report financial results. During the event, it will be possible to ask questions.
Outside the financial result, there will also be a focus on the positive pipeline topline results for its HER2-cVLP breast cancer vaccine announced both in December and January.
ExpreS2ion Biotechnologies is a Danish pharmaceutical company, which focuses on the development of vaccines. Currently the company is developing vaccines against Covid-19, breast cancer and Influenza.
Disclaimer: HC Andersen Capital receives payment from ExpreS2ion Biotechnologies for a Digital IR / Corporate Visibility subscription agreement.